Word

BASILEA

Status

Dead

Status Code

606

Status Date

Monday, November 4, 2019

Serial Number

86936140

Mark Type

3000

Filing Date

Thursday, March 10, 2016

Published for Opposition

Tuesday, August 9, 2016

Abandoned Date

Monday, November 4, 2019

Trademark Owner History

Basilea Pharmaceutica AG - Owner At Publication

Classifications

1 Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

5 Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only

42 Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

The color(s) blue and white is/are claimed as a feature of the mark.
The mark consists of the word "BASILEA" in blue surrounded by an oval in blue, with the interior of the oval in white.

Trademark Events

Nov 4, 2019

Abandonment Notice E-Mailed - No Use Statement Filed

Nov 4, 2019

Abandonment - No Use Statement Filed

May 18, 2019

Corrected Noa E-Mailed

May 16, 2019

Divisional Processing Complete

May 6, 2019

Divisional Request Received

May 6, 2019

Teas Request To Divide Received

Mar 6, 2019

Notice Of Approval Of Extension Request E-Mailed

Mar 5, 2019

Extension 5 Granted

Feb 27, 2019

Extension 5 Filed

Mar 5, 2019

Case Assigned To Intent To Use Paralegal

Feb 27, 2019

Teas Extension Received

Sep 21, 2018

Notice Of Approval Of Extension Request E-Mailed

Sep 19, 2018

Extension 4 Granted

Sep 19, 2018

Extension 4 Filed

Sep 19, 2018

Teas Extension Received

Mar 21, 2018

Notice Of Approval Of Extension Request E-Mailed

Mar 19, 2018

Extension 3 Granted

Mar 19, 2018

Extension 3 Filed

Mar 19, 2018

Teas Extension Received

Sep 26, 2017

Notice Of Approval Of Extension Request E-Mailed

Sep 23, 2017

Extension 2 Granted

Sep 23, 2017

Extension 2 Filed

Sep 23, 2017

Teas Extension Received

Mar 29, 2017

Notice Of Approval Of Extension Request E-Mailed

Mar 27, 2017

Extension 1 Granted

Mar 27, 2017

Extension 1 Filed

Mar 27, 2017

Teas Extension Received

Oct 4, 2016

Noa E-Mailed - Sou Required From Applicant

Aug 9, 2016

Official Gazette Publication Confirmation E-Mailed

Aug 9, 2016

Published For Opposition

Jul 20, 2016

Notification Of Notice Of Publication E-Mailed

Jun 28, 2016

Approved For Pub - Principal Register

Jun 22, 2016

Assigned To Examiner

Mar 16, 2016

Notice Of Design Search Code E-Mailed

Mar 15, 2016

New Application Office Supplied Data Entered In Tram

Mar 14, 2016

New Application Entered In Tram